Redmile Group as of Sept. 30, 2020
Portfolio Holdings for Redmile Group
Redmile Group holds 81 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics (FATE) | 9.3 | $505M | 13M | 39.97 | |
| Amicus Therapeutics (FOLD) | 6.0 | $326M | 23M | 14.12 | |
| Immunomedics | 5.0 | $275M | 3.2M | 85.03 | |
| Argenx Se Sponsored Adr (ARGX) | 4.8 | $260M | 989k | 262.52 | |
| Igm Biosciences (IGMS) | 4.6 | $253M | 3.4M | 73.81 | |
| Deciphera Pharmaceuticals (DCPH) | 4.5 | $245M | 4.8M | 51.30 | |
| Adc Therapeutics Sa SHS (ADCT) | 3.8 | $210M | 6.4M | 32.99 | |
| Allakos (ALLK) | 3.6 | $198M | 2.4M | 81.45 | |
| Gilead Sciences (GILD) | 3.3 | $181M | 2.9M | 63.19 | |
| Oak Street Health | 2.6 | $142M | 2.7M | 53.44 | |
| Annexon (ANNX) | 1.9 | $104M | 3.4M | 30.23 | |
| Epizyme | 1.8 | $99M | 8.3M | 11.93 | |
| 1life Healthcare | 1.7 | $95M | 3.3M | 28.36 | |
| Biogen Idec (BIIB) | 1.7 | $93M | 327k | 283.68 | |
| Nurix Therapeutics (NRIX) | 1.7 | $91M | 2.6M | 34.91 | |
| Atara Biotherapeutics (ATRA) | 1.7 | $90M | 6.9M | 12.96 | |
| Kymera Therapeutics (KYMR) | 1.6 | $88M | 2.7M | 32.31 | |
| Sanofi Sponsored Adr (SNY) | 1.6 | $87M | 1.7M | 50.17 | |
| Biontech Se Sponsored Ads (BNTX) | 1.6 | $86M | 1.2M | 69.23 | |
| Stoke Therapeutics (STOK) | 1.6 | $85M | 2.5M | 33.49 | |
| Beam Therapeutics (BEAM) | 1.5 | $82M | 3.3M | 24.62 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.5 | $80M | 2.4M | 32.69 | |
| Pliant Therapeutics (PLRX) | 1.4 | $77M | 3.4M | 22.65 | |
| Replimune Group (REPL) | 1.4 | $77M | 3.3M | 23.02 | |
| Repare Therapeutics Ord (RPTX) | 1.4 | $74M | 2.4M | 30.77 | |
| Akero Therapeutics (AKRO) | 1.3 | $72M | 2.3M | 30.79 | |
| Cigna Corp (CI) | 1.2 | $67M | 397k | 169.41 | |
| GenMark Diagnostics | 1.2 | $67M | 4.7M | 14.20 | |
| Krystal Biotech (KRYS) | 1.2 | $65M | 1.5M | 43.05 | |
| Allovir (ALVR) | 1.2 | $64M | 2.3M | 27.50 | |
| Nevro (NVRO) | 1.2 | $64M | 460k | 139.30 | |
| Regenxbio Inc equity us cm (RGNX) | 1.1 | $61M | 2.2M | 27.52 | |
| Tcr2 Therapeutics Inc cs | 1.0 | $57M | 2.8M | 20.32 | |
| Aprea Therapeutics | 1.0 | $55M | 2.3M | 24.06 | |
| Boston Scientific Corporation (BSX) | 1.0 | $54M | 1.4M | 38.21 | |
| Scholar Rock Hldg Corp (SRRK) | 0.9 | $51M | 2.9M | 17.69 | |
| Zymeworks | 0.9 | $51M | 1.1M | 46.58 | |
| Neoleukin Therapeutics | 0.9 | $50M | 4.2M | 12.00 | |
| Avita Therapeutics (RCEL) | 0.8 | $45M | 1.8M | 25.16 | |
| Uniqure Nv SHS (QURE) | 0.8 | $42M | 1.1M | 36.83 | |
| Axonics Modulation Technolog (AXNX) | 0.7 | $38M | 741k | 51.04 | |
| ImmunoGen | 0.7 | $38M | 11M | 3.60 | |
| Atreca Cl A Com (BCEL) | 0.7 | $36M | 2.5M | 13.97 | |
| Dex (DXCM) | 0.6 | $34M | 83k | 412.23 | |
| Amedisys (AMED) | 0.6 | $33M | 140k | 236.43 | |
| Ppd | 0.6 | $32M | 853k | 36.99 | |
| Celldex Therapeutics Com New (CLDX) | 0.5 | $30M | 2.0M | 14.83 | |
| ICU Medical, Incorporated (ICUI) | 0.5 | $29M | 158k | 182.76 | |
| Catalent (CTLT) | 0.5 | $28M | 329k | 85.66 | |
| Pra Health Sciences | 0.5 | $28M | 278k | 101.44 | |
| Selectquote Ord (SLQT) | 0.5 | $27M | 1.4M | 20.25 | |
| Tricida | 0.5 | $26M | 2.9M | 9.06 | |
| Luminex Corporation | 0.4 | $24M | 914k | 26.25 | |
| Eidos Therapeutics | 0.4 | $24M | 466k | 50.53 | |
| Immatics SHS (IMTX) | 0.4 | $23M | 2.1M | 10.61 | |
| Ardelyx (ARDX) | 0.3 | $18M | 3.5M | 5.25 | |
| Hookipa Pharma Inc equity (HOOK) | 0.3 | $18M | 1.8M | 9.47 | |
| Cytosorbents Corp Com New (CTSO) | 0.3 | $17M | 2.1M | 7.98 | |
| Alx Oncology Hldgs (ALXO) | 0.3 | $15M | 407k | 37.74 | |
| Cabaletta Bio (CABA) | 0.3 | $15M | 1.4M | 10.84 | |
| Profound Med Corp Com New (PROF) | 0.3 | $15M | 825k | 17.64 | |
| Xeris Pharmaceuticals | 0.3 | $14M | 2.4M | 5.93 | |
| Pandion Therapeutics | 0.2 | $13M | 1.1M | 11.46 | |
| Itamar Med Sponsored Ads | 0.2 | $13M | 625k | 20.34 | |
| Cymabay Therapeutics | 0.2 | $12M | 1.7M | 7.24 | |
| Fs Dev Corp Com Cl A | 0.2 | $11M | 1.0M | 11.20 | |
| Goodrx Hldgs Com Cl A (GDRX) | 0.2 | $11M | 200k | 55.60 | |
| Stereotaxis Com New (STXS) | 0.2 | $11M | 3.1M | 3.58 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.2 | $11M | 2.5M | 4.32 | |
| Invitae (NVTAQ) | 0.2 | $8.5M | 195k | 43.35 | |
| Gritstone Oncology Ord (GRTS) | 0.1 | $8.1M | 3.1M | 2.65 | |
| Ayala Pharmaceuticals Incorporated | 0.1 | $7.9M | 667k | 11.78 | |
| Immunovant (IMVT) | 0.1 | $4.3M | 121k | 35.19 | |
| Outset Med (OM) | 0.1 | $3.5M | 70k | 50.00 | |
| Syros Pharmaceuticals | 0.0 | $1.9M | 212k | 8.84 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.0 | $1.8M | 745k | 2.40 | |
| Wave Life Sciences SHS (WVE) | 0.0 | $1.4M | 164k | 8.49 | |
| Vapotherm | 0.0 | $725k | 25k | 29.00 | |
| Ovid Therapeutics (OVID) | 0.0 | $700k | 122k | 5.74 | |
| Odonate Therapeutics Ord | 0.0 | $338k | 25k | 13.43 | |
| Castlight Health CL B | 0.0 | $12k | 10k | 1.17 |
